New mRNA vaccine could prevent norovirus, Newcastle researchers say

Newcastle researchers are looking to see if a new mRNA vaccine can prevent a notorious stomach bug. The team at the Newcastle ...
WRBL

Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational mRNA Norovirus Vaccine, mRNA-1403

CAMBRIDGE, MA / ACCESSWIRE / September 30, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first participant in the U.S. has been dosed in the Nova 301 Trial, a pivotal Phase 3 randomized ...

Get Ready for a Puke-Filled Winter: Norovirus Is Back With a Vengeance

CDC data indicates that norovirus is back on the warpath and getting plenty of Americans sick.
Opinion

Moderna, Inc. (MRNA) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Piper Sandler 37th Annual Healthcare Conference December 2, 2025 11:00 AM ESTCompany ParticipantsJames Mock - Chief ...

Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates

Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 Expects to expand seasonal vaccine franchise from three to up to six approved products ...